Buprenorphine transdermal skin patch and Moxetumomab Pasudotox-tdfk
Determining the interaction of Buprenorphine transdermal skin patch and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Moxetumomab pasudotox-tdfk Intravenous
- Buprenorphine transdermal skin patch-Moxifloxacin
- Buprenorphine transdermal skin patch-Moxifloxacin (Systemic)
- Buprenorphine transdermal skin patch-Moxifloxacin Hydrochloride
- Buprenorphine transdermal skin patch-Moxifloxacin Injection
- Buprenorphine transdermal skin patch-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Buprenorphine, Buprenorphine Hydrochloride
- Moxetumomab Pasudotox-tdfk-Buprenorphine/naloxone Oromucosal, Sublingual
- Moxetumomab Pasudotox-tdfk-Buproban
- Moxetumomab Pasudotox-tdfk-Bupropion
- Moxetumomab Pasudotox-tdfk-Bupropion and naltrexone
- Moxetumomab Pasudotox-tdfk-Bupropion Extended-Release Tablets